Eli Lilly & Co. Receives Buy Rating from David Risinger Due to Promising Tirzepatide Trial Results and Competitive Tolerability
Leerink Partners analyst David Risinger maintained a Buy rating on Eli Lilly & Co (LLY – Research Report) on January 24 and set a price ...
Hosted on MSN7d
It's about to get a lot harder to buy knock-off Ozempic
Jessica DeBenedetto has only been on compounded tirzepatide for a couple of weeks, but she already feels like it's a life-changer. Her doctor prescribed the cheaper, generic version of the weight-loss ...
pharmaphorum2d
Trials set up filing for Lilly’s tirzepatide in sleep apnoea
Eli Lilly’s diabetes and obesity therapy tirzepatide could find a use as a treatment for obstructive sleep apnoea (OSA) after hitting the mark in a pair of phase 3 trials. OSA is a prevalent ...
Morningstar15d
Lexaria's Oral DehydraTECH-Tirzepatide Reduces Side Effects by Half with Comparable Efficacy Versus Eli Lilly's Injectable GLP-1/GIP Drug Zepbound(R)
Blood glucose reduction and insulin secretion levels from the oral DehydraTECH-tirzepatide were comparable to injected Zepbound® KELOWNA, BC / ACCESSWIRE / January 14, 2025 / Lexaria Bioscience ...
pharmaphorum3d
Tirzepatide gets a big win in obesity-related heart failure
Eli Lilly's tirzepatide has been shown to significantly cut cardiovascular risks in patients with obesity and a form of heart failure with few treatment options, in another big win for the GLP-1 ...
Yahoo Finance28d
Don't Buy Weight-Loss Medication From Unauthorized Sources, UK Health Agency Warns About Risks
In October, NHS England proposed a phased rollout of tirzepatide. Under draft guidance from an independent committee at the National Institute for Health and Care Excellence, tirzepatide has been ...